VBIO Financials

Income Statement
MetricQ2 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
6.4M
R&D
2.7M
SG&A
3.7M
Operating Income
-6424000
EBITDA
-6511000
Net Income
-7103000
EPS (Basic)
$-54.25
EPS (Diluted)
$-54.25
Shares (Diluted)
135.2K
MarketsMoversWatchlist
Valion Bio (VBIO) — Financials